| 0 (0%) | 09-27 09:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.21 | 1-year : | 12.14 |
| Resists | First : | 9.6 | Second : | 10.39 |
| Pivot price | 8.94  |
|||
| Supports | First : | 8.31 | Second : | 6.92 |
| MAs | MA(5) : | 8.56 |
MA(20) : | 9.08 |
| MA(100) : | 9.47 |
MA(250) : | 8.93 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 10 |
D(3) : | 9.4 |
| RSI | RSI(14): 41.8 |
|||
| 52-week | High : | 14.44 | Low : | 5.03 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AVXL ] has closed above bottom band by 35.2%. Bollinger Bands are 5.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.75 - 8.78 | 8.78 - 8.82 |
| Low: | 8.34 - 8.38 | 8.38 - 8.42 |
| Close: | 8.59 - 8.65 | 8.65 - 8.72 |
Wed, 24 Sep 2025
H.C. Wainwright Reiterates Its ‘Buy’ Rating on Anavex Life Sciences Corp. (AVXL) with a $42 Price Target - Yahoo Finance
Mon, 22 Sep 2025
Anavex Life Sciences Corp. $AVXL Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Mon, 15 Sep 2025
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Down 4.8% - Here's What Happened - MarketBeat
Wed, 10 Sep 2025
New Analyst Forecast: $AVXL Given $46.0 Price Target | AVXL Stock News - Quiver Quantitative
Tue, 02 Sep 2025
CNS Drug Developer Anavex Life Sciences to Showcase Pipeline at Major Investment Conference - Stock Titan
Wed, 13 Aug 2025
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 86 (M) |
| Shares Float | 83 (M) |
| Held by Insiders | 3.3 (%) |
| Held by Institutions | 38.3 (%) |
| Shares Short | 25,510 (K) |
| Shares Short P.Month | 24,810 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.07 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -27.5 % |
| Return on Equity (ttm) | -43.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -37 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -15.2 |
| PEG Ratio | 0 |
| Price to Book value | 8.09 |
| Price to Sales | 0 |
| Price to Cash Flow | -20.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|